Netherlands
# |
Name |
Operating Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
22.66%
|
Dec. 31, 2023 | USD 44.64 | 0.29% |
|
Netherlands |
|
2 |
3.50%
|
Dec. 31, 2023 | USD 36.38 | 0.42% |
|
Netherlands |
|
3 |
-0.63%
|
Dec. 31, 2023 | USD 27.32 | 1.49% |
|
Netherlands |
|
4 |
-0.96%
|
Dec. 31, 2023 | USD 129.11 | 4.28% |
|
Netherlands |
|
5 |
-1.99%
|
Dec. 31, 2023 | USD 8.76 | -0.46% |
|
Netherlands |
|
6 |
-34.66%
|
Dec. 31, 2023 | USD 667.09 | 1.81% |
|
Netherlands |
|
7 |
-356.22%
|
Dec. 31, 2023 | USD 40.94 | -1.52% |
|
Netherlands |
|
8 |
-489.09%
|
Dec. 31, 2023 | USD 2.12 | -1.40% |
|
Netherlands |
|
9 |
-638.99%
|
Dec. 31, 2023 | USD 0.98 | -1.01% |
|
Netherlands |
|
10 |
-1,298.56%
|
Dec. 31, 2023 | USD 22.29 | 2.39% |
|
Netherlands |
|
11 |
-1,785.46%
|
Dec. 31, 2023 | USD 15.74 | -0.32% |
|
Netherlands |
The Healthcare company in Netherlands with the highest Operating Income Margin is Qiagen N.V. (NYSE: QGEN) at 22.66%.
The Healthcare company in Netherlands with the lowest Operating Income Margin is uniQure N.V. (NasdaqGS: QURE) at -1,785.46%.
The top 10 Healthcare companies in Netherlands by Operating Income Margin are Qiagen N.V., Koninklijke Ahold Delhaize N.V., Koninklijke Philips N.V., Redcare Pharmacy NV, Pharming Group N.V., argenx SE, Merus N.V., ProQR Therapeutics N.V., LAVA Therapeutics N.V. and NewAmsterdam Pharma Company N.V..
The bottom 10 Healthcare companies in Netherlands by Operating Income Margin are uniQure N.V., NewAmsterdam Pharma Company N.V., LAVA Therapeutics N.V., ProQR Therapeutics N.V., Merus N.V., argenx SE, Pharming Group N.V., Redcare Pharmacy NV, Koninklijke Philips N.V. and Koninklijke Ahold Delhaize N.V..